SCHEMBL1673239

SCHEMBL1673239

CCCCC(CC)Cc1c(C(=O)O)cccc1N(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
CYP3A4 P08684 2/20 0.45
CA2 P00918 2/20 0.45
LMNA P02545 3/20 0.41
HSD17B10 Q99714 1/20 0.41
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
KDM4E B2RXH2 3/20 0.39
TSHR P16473 5/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 3/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11422395 0.88 ALDH1A1 (0.52) ALDH1A1CYP3A4CA2LMNAHSD17B10
SCHEMBL28780898 0.85 ALDH1A1 (0.41) ALDH1A1CYP3A4CA2LMNAHSD17B10
SCHEMBL29672612 0.83 ALDH1A1 (0.48) ALDH1A1CYP3A4CA2LMNAPRSS1
SCHEMBL7165074 0.83 ALDH1A1 (0.48) ALDH1A1CYP3A4CA2LMNAPRSS1
SCHEMBL9281467 0.83 LMNA (0.53) ALDH1A1CYP3A4CA2LMNAPRSS1
SCHEMBL621545 0.82 ALDH1A1 (0.48) ALDH1A1CYP3A4CA2LMNAHSD17B10
SCHEMBL7102381 0.82 ALDH1A1 (0.47) ALDH1A1CYP3A4CA2LMNAHSD17B10
SCHEMBL6684614 0.82 ALDH1A1 (0.47) ALDH1A1CYP3A4CA2LMNAHSD17B10
Isophthalic Acid SCHEMBL27395384 0.81 ALDH1A1 (0.46) ALDH1A1CYP3A4CA2LMNAPRSS1
SCHEMBL1673240 0.80 ALDH1A1 (0.45) ALDH1A1CYP3A4CA2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2485807-A1 SUN-CARE COMPOSITIONS Isp Investments Inc. (US) 2012-08-15 EP claimed
WO-2011044015-A1 SUN-CARE COMPOSITIONS ISP INVESTMENTS INC. (US) 2011-04-14 WO claimed
EP-0583308-B1 ARTIFICIAL TANNING COMPOSITIONS CONTAINING POSITIVELY CHARGED PAUCILAMELLAR VESICLES RICHARDSON VICKS INC (US) 1995-08-23 EP claimed
EP-0559786-B1 LEAVE-ON FACIAL EMULSION COMPOSITIONS RICHARDSON VICKS INC (US) 1995-07-19 EP claimed
JP-3181584-A None JP disclosed
US-20240052204-A1 ADHESIVE BONDING METHOD FOR AUTOMATED PROCESSES SIKA TECHNOLOGY AG (CH) 2024-02-15 US disclosed
EP-4308659-A1 ADHESIVE BONDING METHOD FOR AUTOMATED PROCESSES Sika Technology AG (CH) 2024-01-24 EP disclosed
CN-106019841-A Photosensitive resin composition, pattern forming method, cured film, insulation film, color filter and display device 东京应化工业株式会社 2016-10-12 CN disclosed
EP-1988873-B1 POLYMERS CONTAINING SILICONE COPOLYOL MACROMERS AND PERSONAL CARE COMPOSITIONS CONTAINING SAME LUBRIZOL ADVANCED MAT INC (US) 2013-01-09 EP disclosed
US-8021650-B2 Polymers containing silicone copolyol macromers and personal care compositions containing same LUBRIZOL ADVANCED MATERIALS, INC. (US) 2011-09-20 US disclosed
US-20100256255-A1 JETTABLE INK COMPOSITION STEVENS CHARLES 2010-10-07 US disclosed
US-7735989-B2 Curable inkjet ink E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-15 US disclosed
US-20030147825-A1 Personal care compostions containing inverse emulsion polymers NOVEON IP HOLDINS CORP. 2003-08-07 US disclosed
US-6576702-B2 Prepared by reacting a polyisocyanate and an active hydrogen compounds, dispersing the prepolymer in water, and chain extending the prepolymer by reaction with at least one of water, inorganic or organic polyamine, adding a plasticizer NOVEON IP HOLDINGS CORP. 2003-06-10 US disclosed
EP-1301564-A1 PLASTICIZED WATERBORNE POLYURETHANE DISPERSIONS AND MANUFACTURING PROCESS Noveon IP Holdings Corp. (US) 2003-04-16 EP disclosed
WO-2002100374-A2 PERSONAL CARE COMPOSITIONS CONTAINING INVERSE EMULSION POLYMERS NOVEON IP HOLDINGS CORP. (US) 2002-12-19 WO disclosed
US-20020028875-A1 Plasticized waterborne polyurethane dispersions and manufacturing process NOVEON, INC. 2002-03-07 US disclosed
WO-2002008327-A1 PLASTICIZED WATERBORNE POLYURETHANE DISPERSIONS AND MANUFACTURING PROCESS NOVEON IP HOLDINGS CORP. (US) 2002-01-31 WO disclosed
JP-H03181584-A ULTRAVIOLET LIGHT-SCREENING POWDER AND COSMETIC BLENDED WITH SAME POWDER KOBAYASHI KOSE CO LTD 1991-08-07 JP disclosed
EP-0417606-A2 Method of making highly adsorptive copolymers DOW CORNING CORPORATION (US) 1991-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030147825-A1 Personal care compostions containing inverse emulsion polymers CUTA, POLR1C, TERB1 ALDH1A1 3080/4885CYP3A4 3927/4885CA2 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.